1W Return
1M Return
6M Return
1Y Return
3Y Return
Start SIP in Oxygenta Pharmaceutical Ltd
Stock Performance
52 Week Low - High
Today’s Low - High
Open
Prev. Close
Total Traded Value
Fundamental
Market Cap (in crs)
Face Value
Turnover (in lacs)
Key Metrics
Qtr Change %
246.56% Gain from 52W Low
78.1
TTM PE Ratio
High in industry
13554.9
Price to Book Ratio
Negative Price to Book
-15
Dividend yield 1yr %
0
TTM PEG Ratio
PEG TTM is much higher than 1
135.4
Oxygenta Pharmaceutical Ltd Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
Current Price
5Day EMA
90.80
10Day EMA
90.30
12Day EMA
90.00
20Day EMA
88.70
26Day EMA
87.90
50Day EMA
83.40
100Day EMA
72.30
200Day EMA
58.90
5Day SMA
90.50
10Day SMA
91.30
20Day SMA
86.90
30Day SMA
85.00
50Day SMA
89.40
100Day SMA
67.70
150Day SMA
56.50
200Day SMA
51.10
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 19114 Rs | 19114 Rs |
Week Rs | 17294 Rs | 17294 Rs |
Month Rs | 18539 Rs | 18539 Rs |
Resistance & Support
91.36
Pivot
Resistance
First Resistance
92.58
Second Resistance
95.02
Third Resistance
96.24
Support
First Support
88.92
Second support
87.70
Third Support
85.26
Relative Strength Index
54.45
Money Flow Index
57.22
MACD
2.04
MACD Signal
1.84
Average True Range
3
Average Directional Index
20.66
Rate of Change (21)
27.23
Rate of Change (125)
156.44
Similar stocks
Similar Stocks
Peer comparison
Compare
| Company | Market Price | Market Cap | 52W Low | 52W High |
|---|---|---|---|---|
Lactose (India) Ltd. | - | - | - | |
Oxygenta Pharmaceutical Ltd. | - | - | - | |
Natural Capsules Ltd. | - | - | - | |
Gennex Laboratories Ltd. | - | - | - | |
Fredun Pharmaceuticals Ltd. | - | - | - | |
Vaishali Pharma Ltd. | - | - | - | |
Trident Lifeline Ltd. | - | - | - |
Oxygenta Pharmaceutical Ltd Company background
Founded in: 1990
Managing director: Sai Sudhakar Vankineni
Oxygenta Pharmaceutical Limited (Formerly known S S Organics Ltd) was incorporated as Private Limited Company in year 1990 and converted into a Limited Company in 1993, with the objective of carrying on the business of manufacturing all classes and kinds of Drugs including Pharmaceutical preparation, and Organic Fine Chemicals. Later, the Company changed its name from S.S. Organics Ltd. to Oxygenta Pharmaceutical Limited in 202122.The Company is strong in manufacturing of anti ulcerative and anti bacterial drugs. The Company is doing contract manufacturing work for APL and also having its own production. The Company is engaged in manufacture of bulk drugs. It manufactures a wide range of new generation quinolones, antiasthmatic, antiulcerant, and antiinflammatory drugs. The Company has plant located at Medak in Andhra Pradesh. The Company has been doing contract manufacturing work with APL for manufacturing of Cirprofloxacin HCL from QAcid and has been manufacturing Pantaprozole Sodium and Gabapentine for own production. To minimize the working capital requirement and to have consistent income, it is necessary to continue contract manufacturing work till the Company gets working capital limits from any Bank. This contract manufacturing helps it to meet major operational expenses of the Company. Since the Company started commercial production in July, 2015 after fire accident, it is in the process of stabilizing the manufacturing and marketing.
Oxygenta Pharmaceutical Ltd FAQs
What is the Mutual Fund shareholding in Oxygenta Pharmaceutical Ltd?
The Mutual Fund Shareholding was 0.03% at the end of .
How can I buy Oxygenta Pharmaceutical Ltd shares?
You can easily buy Oxygenta Pharmaceutical Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
Open Demat Account
